U.S. Researchers Develop Room-Temperature Stable Blood Substitute for Battlefield Transfusions

Researchers at Johns Hopkins University’s Applied Physics Laboratory (APL) have achieved a significant milestone in medical science: the development of a stable, room-temperature blood substitute that could be a game-changer for battlefield medicine. This innovative compound, derived from lab-grown red blood cells, aims to address the critical need for immediate blood transfusions in emergency situations, particularly for military personnel.

The project, codenamed HEART (Human Erythrocytes Available for Reconstitution and Transfusion), focuses on creating a reliable and accessible blood product that bypasses the logistical challenges associated with traditional blood banks. Traditional blood donations have a limited shelf life, typically around 42 days when stored under specific temperature conditions. This necessitates robust infrastructure, trained personnel, and a constant supply chain, all of which can be difficult to maintain in combat zones.

Key facts

Tackling Battlefield Needs

The inherent difficulties of providing timely transfusions to wounded soldiers have long been a concern for military medical planners. Mobile blood banks, while an improvement, still present significant logistical hurdles. These include the need for medical supplies, trained staff for donation and transfusion, accurate tracking of blood types among combatants, and secure storage facilities. The APL team’s research directly addresses these vulnerabilities.

“As we prepare for potential engagements anywhere in the world, a secure supply of blood is a fundamental component of the armed forces’ readiness and response capability,” noted Suzy Kennedy, program area manager at APL. This sentiment underscores the strategic importance of the HEART project.

Innovative Approach to Red Blood Cells

At the core of the HEART project is a novel method for producing red blood cells outside the human body. Claire Bell, a senior molecular biologist at APL, explained the project’s philosophy: “Our research is based on the idea that the best substitute for red blood cells is precisely, red blood cells, without the need for a donor.” This approach sidesteps the complexities and limitations of finding suitable donors in critical situations.

Bell, along with biomedical engineer Corrine Fuller, leveraged stem cells and organoids—cell clusters that mimic organ functions—to create a bone marrow-like organoid capable of producing red blood cells. The decision to use lab-generated red blood cells stemmed from the inherent challenges of obtaining them from human donors in sufficient quantities and under the required conditions for this specific application.

The Development Process

Once the red blood cells were successfully produced in the laboratory, they underwent a dehydration process after the addition of cryoprotectants. This resulted in a powdered substance that retains the essential proteins and sugars found in natural blood. Crucially, this dried product can be easily rehydrated with sterile saline solution.

The resulting reconstituted blood substitute is safe and effective at room temperature, offering universal donor compatibility equivalent to O-negative blood. This means that in a battlefield scenario, soldiers or medical teams would only need to carry a small container of the lyophilized cells and saline solution to prepare a potentially life-saving transfusion.

The implications of this advancement are profound, offering a more robust and responsive solution for emergency medical care where traditional blood supply chains are compromised. The ability to store and transport blood components without refrigeration significantly enhances readiness and survivability in austere environments.

Source: Clarin Deportes – https://www.clarin.com/estados-unidos/cientificos-dan-credito-universidad-hopkins-presenta-avance-inedito-creacion-sustituto-sangre-estable-temperatura-ambiente_0_AHejY42C18.html